Institut Pasteur

Request correction

Professional services

Unclaimed

A French nonprofit biomedical research foundation advancing science, public health, training, and medical innovation.

Last updated November 4, 2026

AI crawler reads

No AI crawler has read this profile yet.

Overview

Institut Pasteur is a French nonprofit biomedical research foundation headquartered in Paris. Established in 1887 through an international fundraising effort inspired by Louis Pasteur’s work on infectious disease and vaccination, it was created to continue laboratory research, develop preventive and therapeutic applications, and train scientists and physicians. The institution is named after Pasteur, whose research on microorganisms, fermentation, disease transmission, and immunization helped establish modern microbiology and germ theory. The Institut Pasteur operates primarily as a research and public-health institution rather than as a conventional commercial brand. Its scientific activities span infectious diseases, microbiology, immunology, virology, bacteriology, parasitology, antimicrobial resistance, emerging pathogens, cancer biology, human genetics, neuroscience, and the biology of living systems. The organization also contributes to epidemiological surveillance, reference laboratory work, outbreak response, scientific education, and the transfer of discoveries into diagnostics, vaccines, medicines, and other health applications. Its international identity is reinforced by the Pasteur Network, a group of affiliated and partner institutions located in countries across multiple regions. These institutes adapt Pasteurian research and public-health methods to local disease burdens and health-system needs. The network has supported work on diseases including tuberculosis, HIV/AIDS, malaria, dengue, rabies, influenza, yellow fever, Ebola, SARS-related viruses, and other emerging infections. Individual network members may have distinct legal status, public mandates, manufacturing capabilities, and national ownership arrangements; they should not automatically be treated as subsidiaries of the Paris foundation. Funding combines public and research support, partnerships, intellectual-property licensing, institutional activities, and private philanthropy. Donations are an important part of the organization’s public-facing model, and fundraising communications commonly connect support for research with preparedness for epidemics, cancer, neurological disease, and other health challenges. Research valorization may include patents, licenses, and collaborations with universities, foundations, biotechnology companies, pharmaceutical groups, and public-health agencies. The Institut Pasteur’s brand positioning combines scientific excellence, humanitarian purpose, international cooperation, and practical impact. Its public communications increasingly seek to make complex research understandable and to show why continuous scientific work matters during periods of epidemic, social, or environmental disruption. The institution remains active as a research, education, public-health, and innovation organization, with Paris as its central campus and a broad international network.

History

Institut Pasteur was founded in Paris in 1887 after Louis Pasteur’s successful public demonstrations and research on vaccination, especially his work on rabies. The institution was designed as a durable scientific foundation combining research, medical application, and teaching. Its early laboratories attracted scientists from France and abroad and helped establish a model in which laboratory investigation, clinical observation, disease surveillance, and professional training could reinforce one another. During its first decades, Pasteurian researchers made important contributions to bacteriology, immunology, serology, parasitology, and infectious-disease control. The Paris institute also inspired the creation of related institutes and laboratories abroad. Over time, these collaborations developed into a large international network whose members investigate diseases relevant to their regions while maintaining scientific links with Paris and with one another. The institution’s work expanded beyond the diseases most closely associated with Pasteur’s original era. Research programs came to include viruses, bacterial resistance, malaria, HIV, influenza, hepatitis, dengue, tuberculosis, cancer, genetics, neurobiology, and emerging infections. The organization also developed reference-laboratory and public-health functions, including laboratory support for surveillance and epidemic response. Its role has therefore extended from discovery science into preparedness, diagnostics, training, and the application of research findings. A major part of the Institut Pasteur model is the translation of discoveries into usable health tools. Researchers collaborate with universities, public agencies, foundations, and industry; intellectual property can be protected and licensed, while scientific partnerships support vaccine, diagnostic, and therapeutic development. Such arrangements have included work with the Mérieux ecosystem and vaccine developers using technologies originally developed by Institut Pasteur scientists. These relationships are intended to extend the reach of research while preserving the foundation’s nonprofit scientific mission. The institution is also sustained by public support and philanthropy. Fundraising campaigns have emphasized the long time horizon of biomedical research and the need to maintain laboratories during health emergencies. Public-facing communication has evolved from traditional donor outreach to email, online giving, social media, television, and influencer-supported campaigns. The organization’s communications increasingly present science as both rigorous and human-centered, connecting research to individual lives and global health security. In the 2010s and 2020s, Institut Pasteur continued to strengthen cross-border partnerships. Scientific cooperation with Japanese universities and health-security organizations led to Pasteur International Units and later institutional initiatives in Japan. Agreements with Institut Curie focused on cancer, immunology, genetics, and related disciplines. Cooperation with the International Vaccine Institute expanded joint vaccine work. The wider Pasteur Network also remained involved in surveillance, outbreak response, training, diagnostics, and vaccine manufacturing, including initiatives linked to Africa. The modern Institut Pasteur presents itself as a global biomedical research institution organized around four broad functions: research, public health, training, and development of research applications. Its central Paris campus remains the symbolic and scientific core, while the international network gives the brand a wider identity. The organization is active and internationally famous, but individual Pasteur-branded institutes outside France can have separate legal identities and national mandates.

2025
New brand platform and visual identity
[5]Institut Pasteur brand positioning articlecercledubranding.fr
A reported brand refresh simplified the visual system and adopted the promise “For every life, science acts,” emphasizing accessibility, universality, and the centrality of science.
2024
Expanded vaccine partnership with IVI
[4]Institut Pasteur and IVI memorandum of understandingpasteur.fr
A memorandum of understanding broadened cooperation on vaccine research and global-health funding.
2022
Strategic agreement with Institut Curie
[3]Institut Pasteur and Institut Curie strategic agreementpasteur.fr
The foundations agreed to deepen cooperation in cancer biology, immunology, genetics, biophysics, and chemistry.
2019
Institut Pasteur Japan Office opens
[8]Institut Pasteur Japan Office openspasteur.fr
The opening marked a new institutional phase in long-running French-Japanese scientific cooperation.
2013
125th-anniversary brand campaign
[7]125th-anniversary brand campaignlareclame.fr
A public campaign used the theme of curiosity to celebrate the institution’s history and communicate its contribution to medical research.
2010
Mérieux Alliance research partnership
[6]Mérieux Alliance research partnershippasteur.fr
Institut Pasteur and Mérieux Alliance announced joint infectious-disease research and a framework for potential research valorization.
1895
Death of Louis Pasteur
[1]Institut Pasteur historypasteur.fr
After Pasteur’s death, the institution continued his research and educational mission under a succession of scientific leaders.
1887
Foundation of Institut Pasteur
[1]Institut Pasteur historypasteur.fr
Institut Pasteur was established in Paris as a scientific foundation inspired by Louis Pasteur’s work and supported by international philanthropy.

Products and positioning

A globally recognized, nonprofit biomedical research and public-health institution linking fundamental science with disease prevention, training, and medical applications.

Research · 1887
Biomedical research
Core scientific programs investigate infectious diseases, microbiology, immunology, cancer, genetics, neuroscience, antimicrobial resistance, and the biology of living systems. Work ranges from fundamental discovery to translational research intended to support diagnostics, vaccines, medicines, and public-health practice.
Public health
Public-health and reference laboratory services
Institut Pasteur contributes laboratory expertise, epidemiological investigation, surveillance, training, and outbreak-response capacity. These functions connect research teams with national and international health authorities and with members of the Pasteur Network.
Technology transfer
Research applications and licensing
Discoveries may be protected through patents and transferred through licenses or partnerships. This pathway allows external biotechnology and pharmaceutical organizations to develop selected technologies while the institute continues its nonprofit research and public-health mission.
Education · 1887
Scientific training
Training is a central institutional activity, supporting researchers, physicians, laboratory professionals, and public-health specialists through courses, scientific exchanges, and international collaborations.

Marketing campaigns

2025New brand platform and identity
France · International Pasteur Network
The Good Design and The Good Company worked on a revised brand platform, visual identity, and narrative intended to make the institute’s mission more contemporary, clear, and accessible.
Outcome. The reported new promise, “For every life, science acts,” positions scientific excellence, humanism, and universal impact together.
Source
2021Research must move forward
France
A campaign used the message that research must continue even when crises disrupt everyday life, encouraging public support for uninterrupted scientific work.
Outcome. The campaign returned to television toward the end of the year and emphasized philanthropy as a major source of support.
Source
2019Z Event fundraising campaign
France · Online international audience
More than 50 online streamers participated in the 2019 Z Event, a long-form livestream fundraising event supporting Institut Pasteur.
Outcome. The campaign reportedly raised more than €3.5 million, according to the referenced marketing-industry account.
Source
2013125th-anniversary institutional campaign
France
A television and public-awareness campaign marked the institute’s 125th anniversary and linked its history of discovery to the value of curiosity in science.
Outcome. The campaign strengthened anniversary visibility and presented biomedical research as a source of continuing discovery.
Source
Email and telephone donor-acquisition test
France
Institut Pasteur tested coordinated email and telephone outreach to broaden its donor base, using segmented messages about cancer and meningitis and follow-up based on recipients’ digital behavior.
Outcome. The referenced account describes the activity as a test of newer digital acquisition and online-donation methods; a final performance result is not provided.
Source

Brand decisions

2025
Refresh the brand platform and visual identityStrategy
Background
The institution sought clearer communication of its mission amid public-health crises, media saturation, and pressure to engage philanthropic audiences.
Action taken
A new narrative platform, visual identity, typography, color approach, and simplified logo were developed for contemporary and digital use.
Aftermath
The reported positioning centers on the relationship between science, human life, and universal public-health impact.
Source
2024
Expand vaccine collaboration with the International Vaccine InstituteStrategy
Background
Global health threats and the need for faster vaccine development created a rationale for closer cooperation between the two research organizations.
Action taken
The parties signed a memorandum covering joint scientific projects and combined efforts to secure project funding.
Aftermath
The agreement established a broader framework for vaccine-oriented global-health work.
Source
2022
Deepen strategic cooperation with Institut CurieStrategy
Background
Both foundations identified opportunities to combine expertise in cancer, immunology, genetics, biophysics, and chemistry.
Action taken
They signed a framework agreement to coordinate a new collaborative research strategy.
Aftermath
The agreement created a basis for cross-disciplinary French research collaboration.
Source
2010
Enter strategic infectious-disease research partnership with Mérieux AllianceStrategy
Background
The institute sought collaborative approaches that combined academic expertise with the development capabilities of a major bioindustrial group.
Action taken
Institut Pasteur and Mérieux Alliance identified joint projects in virology, bacteriology, and immunology, with possible use of results by Mérieux companies and potential patent development.
Aftermath
The agreement added to the institute’s network of translational and industrial collaborations.
Source

Sources11 sources

Cite this profile: Cite the canonical profile. /brand-wiki/institut-pasteur · Editorial policy · How profiles are compiled